Steven E. Coutre
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL (NCT03045328) | Steven E. Coutre | 2017-09-26 |
Track Steven E. Coutre automatically
Every clearance here is in the API, with alerts when new ones post.